levoleucovorin has been researched along with Cystic-Fibrosis* in 3 studies
1 review(s) available for levoleucovorin and Cystic-Fibrosis
| Article | Year |
|---|---|
Gastrointestinal malignancy in cystic fibrosis.
Cystic fibrosis (CF) is a multisystem disease affecting the gastrointestinal (GI) tract as well as the lungs. As survival has increased significantly over the past few decades, complications not seen previously have become apparent. There is an overall increased rate of malignancy in CF, particularly from the GI tract and in the post-transplant population. The most common sites of malignancy are the pancreatico-biliary and digestive tract, as well as an increased rate of testicular cancer. Using an illustrative case of metastatic oesophageal malignancy which initially appeared to be hepatic in origin, we have reviewed the literature surrounding malignancy in CF with a particular focus on the GI tract. Topics: Adenocarcinoma, Clear Cell; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cystic Fibrosis; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leucovorin; Liver Neoplasms; Male; Organoplatinum Compounds | 2020 |
2 other study(ies) available for levoleucovorin and Cystic-Fibrosis
| Article | Year |
|---|---|
Colonic adenocarcinoma in a 13-year-old with cystic fibrosis.
The increase in longevity among patients with cystic fibrosis has brought to light comorbidities associated with the disease that are less acutely fatal than its pulmonary manifestations. Modern retrospective analysis has demonstrated an increased risk of gastrointestinal malignancy in patients with cystic fibrosis, with a marked elevation in malignancy rates among patients in their 20s and 30s. Here we report a case of colonic adenocarcinoma presenting as pneumaturia in a 13-year-old patient with cystic fibrosis. Topics: Adenocarcinoma; Adolescent; Air; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Colectomy; Combined Modality Therapy; Cystic Fibrosis; Fluorouracil; Humans; Intestinal Fistula; Leucovorin; Male; Organoplatinum Compounds; Oxaliplatin; Ultrasonography; Urinary Bladder Fistula; Urine | 2007 |
From the Food and Drug Administration.
Topics: Cystic Fibrosis; Deoxyribonuclease I; Deoxyribonucleases; Drug Approval; Drug Therapy, Combination; Humans; Leucovorin; Naproxen; Nonprescription Drugs; Orphan Drug Production; Pneumonia, Pneumocystis; Recombinant Proteins; Trimetrexate; United States; United States Food and Drug Administration | 1994 |